Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. SPY
2. PATH
3. KBH
4. AZO
5. USO
6. QQQ
7. ORCL
8. RCL
9. ONON
10. BA

Go back to Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44
(NASDAQ: TRDA) Delayed: 6.50 -0.21 (3.13%)
Previous Close $6.71    52 Week High $ 
Open $6.71    52 Week Low $ 
Day High $6.71    P/E N/A 
Day Low $6.37    EPS $ 
Volume 282,800